Design, synthesis, and biological evaluation of bifunctional thyrointegrin inhibitors: new anti-angiogenesis analogs

References

• Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285:1028–1032.
   PubMed Web of Science ®Google Scholar
• Schwartz MA. Integrin signaling revisited. Trends Cell Biol 2001;11:466–470.
   PubMed Web of Science ®Google Scholar
• Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673–687.
   PubMed Web of Science ®Google Scholar
• Kinbara K, Goldfinger LE, Hansen M, Chou FL, Ginsberg MH. Ras GTPases: integrins’ friends or foes? Nat Rev Mol Cell Biol 2003;4:767–776.
   PubMed Web of Science ®Google Scholar
• Boudreau NJ, Jones PL. Extracellular matrix and integrin signalling: the shape of things to come. Biochem J 1999;339 (Pt 3):481–488.
   Google Scholar
• Brakebusch C, Fässler R. The integrin-actin connection, an eternal love affair. Embo J 2003;22:2324–2333.
   PubMed Web of Science ®Google Scholar
• Burridge K, Fath K, Kelly T, Nuckolls G, Turner C. Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu Rev Cell Biol 1988;4:487–525.
   PubMedGoogle Scholar
• Ingber DE. Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy. Semin Cancer Biol 1992;3:57–63.
   PubMedGoogle Scholar
• Sun HW, Li CJ, Chen HQ, Lin HL, Lv HX, Zhang Y et al. Involvement of integrins, MAPK, and NF-kappaB in regulation of the shear stress-induced MMP-9 expression in endothelial cells. Biochem Biophys Res Commun 2007;353:152–158.
   PubMed Web of Science ®Google Scholar
• Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157–1164.
   PubMed Web of Science ®Google Scholar
• Lewis JM, Truong TN, Schwartz MA. Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proc Natl Acad Sci USA 2002;99:3627–3632.
   PubMed Web of Science ®Google Scholar
• Wang XQ, Sun P, Paller AS. Inhibition of integrin-linked kinase/protein kinase B/Akt signaling: mechanism for ganglioside-induced apoptosis. J Biol Chem 2001;276:44504–44511.
   PubMed Web of Science ®Google Scholar
• Giancotti FG. Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol 1997;9:691–700.
   PubMed Web of Science ®Google Scholar
• Zheng DQ, Fornaro M, Bofetiado CJ, Tallini G, Bosari S, Languino LR. Modulation of cell proliferation by the integrin cytoplasmic domain. Kidney Int 1997;51:1434–1440.
   Google Scholar
• Watt FM. Role of integrins in regulating epidermal adhesion, growth and differentiation. Embo J 2002;21:3919–3926.
   PubMed Web of Science ®Google Scholar
• Yamada KM, Even-Ram S. Integrin regulation of growth factor receptors. Nat Cell Biol 2002;4:E75–E76.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Engvall E. Integrins and vascular extracellular matrix assembly. J Clin Invest 1997;99:1149–1152.
   PubMed Web of Science ®Google Scholar
• Mousa S A, Davis F B, Davis P J. Hormone-integrin cross talk and angiogenesis modulation. Immunol Endocr Metab Agents Med Chem 2009;9:75–83.
   Google Scholar
• Gottschalk KE, Günther R, Kessler H. A three-state mechanism of integrin activation and signal transduction for integrin alpha(v)beta(3). Chembiochem 2002;3:470–473.
   Google Scholar
• Truong T, Sun G, Doorly M, Wang JY, Schwartz MA. Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl. Proc Natl Acad Sci USA 2003;100:10281–10286.
   PubMedGoogle Scholar
• Puigvert JC, Huveneers S, Fredriksson L, op het Veld M, van de Water B, Danen EH. Cross-talk between integrins and oncogenes modulates chemosensitivity. Mol Pharmacol 2009;75:947–955.
   Google Scholar
• Brozovic A, Majhen D, Roje V, Mikac N, Jakopec S, Fritz G et al. alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species. Mol Pharmacol 2008;74:298–306.
   PubMed Web of Science ®Google Scholar
• Luna J, Tobe T, Mousa SA, Reilly TM, Campochiaro PA. Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. Lab Invest 1996;75:563–573.
   PubMed Web of Science ®Google Scholar
• Mousa SA, Mousa AS. Angiogenesis inhibitors: current & future directions. Curr Pharm Des 2004;10:1–9.
   PubMed Web of Science ®Google Scholar
• Wary KK. Molecular targets for anti-angiogenic therapy. Curr Opin Mol Ther 2004;6:54–70.
   Google Scholar
• Mousa SA. Anti-integrins as a potential therapeutic target in angiogenesis. Expert Opin Ther Patents 1999;9:1237–1248.
   Web of Science ®Google Scholar
• Mousa SA. Angiogenesis Inhibitors and Stimulators: Potential Therapeutic Implications. Texas: Landes Bioscience, 2000.
   Google Scholar
• Giannis A, Rübsam F. Integrin antagonists and other low molecular weight compounds as inhibitors of angiogenesis: new drugs in cancer therapy. Angew Chem Int Ed Engl 1997;36:588–590.
   Google Scholar
• Zitzmann S, Ehemann V, Schwab M. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res 2002;62:5139–5143.
   PubMed Web of Science ®Google Scholar
• Weber WA, Haubner R, Vabuliene E, Kuhnast B, Wester HJ, Schwaiger M. Tumor angiogenesis targeting using imaging agents. Q J Nucl Med 2001;45:179–182.
   PubMedGoogle Scholar
• Urbinati C, Mitola S, Tanghetti E, Kumar C, Waltenberger J, Ribatti D et al. Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 2005;25:2315–2320.
   PubMed Web of Science ®Google Scholar
• Temming K, Schiffelers RM, Molema G, Kok RJ. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist Updat 2005;8:381–402.
   PubMed Web of Science ®Google Scholar
• Ramsden JD. Angiogenesis in the thyroid gland. j Endocrinol 2000;166:475–480.
   PubMed Web of Science ®Google Scholar
• Mousa SA, Bergh JJ, Dier E, Rebbaa A, O’Connor LJ, Yalcin M et al. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. Angiogenesis 2008;11:183–190.
   PubMed Web of Science ®Google Scholar
• Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab 2009;297:E1238–E1246.
   Google Scholar
• Lei J, Nowbar S, Mariash CN, Ingbar DH. Thyroid hormone stimulates Na-K-ATPase activity and its plasma membrane insertion in rat alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2003;285:L762–L772.
   PubMed Web of Science ®Google Scholar
• Lei J, Mariash CN, Bhargava M, Wattenberg EV, Ingbar DH. T3 increases Na-K-ATPase activity via a MAPK/ERK1/2-dependent pathway in rat adult alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008;294:L749–L754.
   PubMed Web of Science ®Google Scholar
• Scarlett A, Parsons MP, Hanson PL, Sidhu KK, Milligan TP, Burrin JM. Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin alphaVbeta3. J Endocrinol 2008;196:509–517.
   PubMed Web of Science ®Google Scholar
• Mousa SA, Davis FB, Mohamed S, Davis PJ, Feng X. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model. Int Angiol 2006;25:407–413.
   PubMed Web of Science ®Google Scholar
• Mousa SA, O’Connor L, Davis FB, Davis PJ. Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology 2006;147:1602–1607.
   Google Scholar
• Yalcin M, Lansing L, Bharali D, Bridoux A, Davis FB, Lin HY, Rebbaa A, Davis PJ, Mousa SA. 79th Annual Meeting of The American Thyroid Association. Chicago, IL: Abstract 110, 2008.
   Google Scholar
• Rebbaa A, Chu F, Davis FB, Davis PJ, Mousa SA. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent. Angiogenesis 2008;11:269–276.
   PubMed Web of Science ®Google Scholar
• Maas JW, Le Noble FA, Dunselman GA, de Goeij AF, Struyker Boudier HA, Evers JL. The chick embryo chorioallantoic membrane as a model to investigate the angiogenic properties of human endometrium. Gynecol Obstet Invest 1999;48:108–112.
   PubMed Web of Science ®Google Scholar
• Akhtar N, Dickerson EB, Auerbach R. The sponge/Matrigel angiogenesis assay. Angiogenesis 2002;5:75–80.
   PubMedGoogle Scholar
• Baffour R, Garb JL, Kaufman J, Berman J, Rhee SW, Norris MA et al. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J Surg Res 2000;93:219–229.
   PubMed Web of Science ®Google Scholar
• Mousa SA. Cell adhesion molecules: potential therapeutic & diagnostic implications. Mol Biotechnol 2008;38:33–40.
   PubMed Web of Science ®Google Scholar
• Gadbois DM, Bradbury EM, Lehnert BE. Control of radiation-induced G1 arrest by cell-substratum interactions. Cancer Res 1997;57:1151–1156.
   PubMedGoogle Scholar
• Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 2001;61:2744–2750.
   PubMed Web of Science ®Google Scholar
• Lisiak E, Cordes N. Integrins and the cellular radiation response. Cancer Ther 2004;2:271–278.
   Google Scholar
• Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003;300:1155–1159.
   PubMed Web of Science ®Google Scholar
• Dimitrijevic-Bussod M, Balzaretti-Maggi VS, Gadbois DM. Extracellular matrix and radiation G1 cell cycle arrest in human fibroblasts. Cancer Res 1999;59:4843–4847.
   PubMed Web of Science ®Google Scholar
• Sloan EK, Pouliot N, Stanley KL, Chia J, Moseley JM, Hards DK et al. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res 2006;8:R20.
   PubMed Web of Science ®Google Scholar
• Felding-Habermann B, O’Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH et al. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 2001;98:1853–1858.
   PubMed Web of Science ®Google Scholar
• Cordes N, Meineke V. Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro. Strahlenther Onkol 2003;179:337–344.
   PubMed Web of Science ®Google Scholar
• Hallahan D, Geng L, Qu S, Scarfone C, Giorgio T, Donnelly E et al. Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell 2003;3:63–74.
   PubMed Web of Science ®Google Scholar
• Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 1999;93:1658–1667.
   PubMed Web of Science ®Google Scholar
• Gardiner EJ, Willett P, Artymiuk PJ. Graph-theoretic techniques for macromolecular docking. J Chem Inf Comput Sci 2000;40:273–279.
   Google Scholar
• Moitessier N, Henry C, Maigret B, Chapleur Y. Combining pharmacophore search, automated docking, and molecular dynamics simulations as a novel strategy for flexible docking. Proof of concept: docking of arginine-glycine-aspartic acid-like compounds into the alphavbeta3 binding site. j Med Chem 2004;47:4178–4187.
   PubMed Web of Science ®Google Scholar
• Cody V, Davis PJ, Davis FB. Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. Steroids 2007;72:165–170.
   PubMed Web of Science ®Google Scholar
• Wilkinson JH. Synthesis of some possible metabolites of thyroxine and triiodothyronine. Biochem j 1956;63:601–605.
   Google Scholar
• Baxter JD, Goede P, Apriletti JW, West BL, Feng W, Mellstrom K et al. Structure-based design and synthesis of a thyroid hormone receptor (TR) antagonist. Endocrinology 2002;143:517–524.
   PubMedGoogle Scholar
• Yokoyama N, Walker GN, Main AJ, Stanton JL, Morrissey MM, Boehm C et al. Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronine. J Med Chem 1995;38:695–707.
   PubMed Web of Science ®Google Scholar
• Xiong JP, Stehle T, Goodman SL, Arnaout MA. New insights into the structural basis of integrin activation. Blood 2003;102:1155–1159.
   PubMed Web of Science ®Google Scholar
• Xiong JP, Stehle T, Zhang R, Joachimiak A, Frech M, Goodman SL et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 2002;296:151–155.
   PubMed Web of Science ®Google Scholar
• Marinelli L, Lavecchia A, Gottschalk KE, Novellino E, Kessler H. Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design. J Med Chem 2003;46:4393–4404.
   PubMed Web of Science ®Google Scholar
• Henry C, Moitessier N, Chapleur Y. Vitronectin receptor alpha(V)beta(3) integrin antagonists: chemical and structural requirements for activity and selectivity. Mini Rev Med Chem 2002;2:531–542.
   Google Scholar
• Mousa SA. alphav Vitronectin receptors in vascular-mediated disorders. Med Res Rev 2003;23:190–199.
   Google Scholar
• Mousa SA. Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications. Curr Opin Chem Biol 2002;6:534–541.
   PubMed Web of Science ®Google Scholar
• Mousa SA. Angiogenesis promoters and inhibitors: potential therapeutic implications. Mol Med Today 1996;2:140–142.
   PubMedGoogle Scholar
• Kerr JS, Slee AM, Mousa SA. The alpha v integrin antagonists as novel anticancer agents: an update. Expert Opin Investig Drugs 2002;11:1765–1774.
   PubMed Web of Science ®Google Scholar
• Bridoux A, Cui H, Dyskin E, Yalcin M, Mousa SA. Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators. Bioorg Med Chem Lett 2009;19:3259–3263.
   Google Scholar
• Davis FB, Mousa SA, O’Connor L, Mohamed S, Lin HY, Cao HJ et al. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 2004;94:1500–1506.
   PubMed Web of Science ®Google Scholar
• Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S et al. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005;146:2864–2871.
   PubMed Web of Science ®Google Scholar
• Davis PJ, Davis FB, Cody V. Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab 2005;16:429–435.
   PubMedGoogle Scholar
• Tucker GC. Inhibitors of integrins. Curr Opin Pharmacol 2002;2:394–402.
   PubMed Web of Science ®Google Scholar
• Tucker GC. Alpha v integrin inhibitors and cancer therapy. Curr Opin Investig Drugs 2003;4:722–731.
   PubMedGoogle Scholar
• Crater WdeC. Nitration. Ind Eng Chem 1951;43:1987–1990.
   Google Scholar
• Clugston M, Flemming R (eds). Advanced Chemistry (Advanced Science). USA: Oxford University Press, 2000, p. 326.
   Google Scholar
• Skinner HF. Metamphetamine synthesis via hydriodic acid/red phosphorus reduction of ephedrine. Forensic Sci Int 1990;48:123–134.
   Google Scholar
• McCullagh JV, Daggett KA. Synthesis of triarylmethane and xanthenes dyes using electrophilic aromatic substitution reactions. J Chem Educ 2007;84:1799.
   Web of Science ®Google Scholar
• Vaidyanathan G, Shankar S, Affleck DJ, Alston K, Norman J, Welsh P et al. Meta-iodobenzylguanidine derivatives containing a second guanidine moiety. Bioorg Med Chem 2004;12:1649–1656.
   Google Scholar
• Sham HL, Zhao C, Stewart KD, Betebenner DA, Lin S, Park CH et al. A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. J Med Chem 1996;39:392–397.
   Google Scholar